About Us

The Clinical Imaging Facility, is a joint venture between Swansea University and Abertawe Bro Morgannwg University Local Health Board. The principles behind the development are medical research and education with improved health gain for the population. The CIF primary role is as a centre for facilitating clinical research, the three main strands of which are pharmaceutical based clinical research in oncology, clinical application of MRI and the development of imaging based clinical pathways.

Further Information


The centre  provides access to MRI and CT scanning, covering Neuro, MSK, vascular, body, cardiac and gynaecological imaging areas on adult patients over the age of 18 years of age undertaken by qualified SOR radiographers who are registered with the HCPC.

 MRI Scanning – Neuro-imaging; cognitive neurochemistry; cognitive control; self-control. behaviour analysis; experimental psychopathology (e.g., fear conditioning and avoidance learning); gambling. Medical imaging research; MSK, Soft tissue scanning, refining surgical techniques and medical applications and devices. Special interest in DWI, Spectroscopy and DTI are underway in the unit as an area of R&D.

CT Scanning – is primarily used to help to make a cancer diagnosis or assess the effects of cancer treatment for example in Clinical Oncology Trials.


The imaging centre houses a 3T Siemens Magnetom MRI Scanner on the ground floor within the Institute of Life Science 2 building. It is the latest Siemens 3T Magnetom Skyra MRI scanner, with a wider (70cm) and shorter (173cm) bore to aid in participant compliance and comfort, without compromising image quality. We have a large collection of high density coils for neuro, body and orthopaedic scanning, together with the TIM 4th generation system with multi channel to support ultra high density coils. The undockable table with integrated spine coils holds up to 250kg.

The MRI suite hardware includes an infusion pump for IV injections and fMRI screen and responses boxes. CIF  is an approved IDEA software user which will allow bespoke scanning protocols to be generated. Facilities for data analysis and high performance computing are also available.

CT scanning is provided by a Siemens Somatom Definition AS CT Scanner which maximizes clinical outcomes and minimizes dose to take best care of patients’ well-being. It has FAST CARE technology which accelerates workflow and lowers radiation exposure to previously unseen levels, thus leveraging untapped potential in patient-centric productivity.

FAST –  Fully Assisting Scanner Technologies – make time-consuming and complex procedures faster as well as far more intuitive. Thus they make scanning more reproducible and less prone to errors. Ideal for clinical trial data.

CARE – Combined Applications to Reduce Exposure – give excellent image quality at the lowest possible dose.

Together with syngo.via, our system enables a streamlined complete examination, from scan preparation to data evaluation, ensuring a highly-reliable diagnosis with the least burden on patients.

  • Immediate, organ-based scan and recon range setting with FAST Planning
  • FAST Adjust allows intuitive scan parameter adjustment with the push of a button
  • Higher reliability and reproducibility in cardiac CT with the FAST Cardio Wizard
  • Image evaluation with a single click with syngo.via


Guidance for Research Project

Project Application Forms word document

Flow chart  PDF

Patient questionnaires word document

Initial enquires should be addressed to the CIF Operational Lead, Paola Griffiths at paola.a.griffiths@swansea.ac.uk . A project application form needs to be completed with the study and returned for an overview of the project. A study is defined as any programme of work that will require access to CIF Imaging resources. This spans the full range of activity from short pilot, start up studies to major grant applications aimed at internal and/or external sponsors. Publication from work carried out at CIF should carry due acknowledgment.

The category of study participant group will affect the pathway followed to access to Clinical Imaging Facility . If the cohort are health board patients, the R&D ABMU department will need to be contacted and they will facilitate the project application with IRAS and specific imaging project template via Jemma.Hughes@wales.nhs.uk. If the cohort are volunteers and not patients, the correct pathway is through CIF via Paola.A.Griffiths@swansea.ac.uk.A feasibility meeting will be scheduled to discuss the project in more detail and areas covered are ethics, subject selection and recruitment, experimental design, software implementation, project implementation, completion timescales and costs. Studies that involve Human Participants will require the Principle Investigator to complete an Ethics Approval from the relevant College or the local NHS Research Ethics Committee. No project can start without Ethics approval. A copy of which will need to be forwarded  to CIF. All projects will need to be peer reviewed by either the Joint Scientific Committee at JCRF or a peer review committee at the relevant college. A copy of which will need to be forward to CIF. The Medicines and Healthcare Products Regulatory Agency, MHRA who are responsible for regulating all medicines and medical devices in the UK by ensuring they work and are acceptably safe may need to be contacted if the project involves a drug or device.

The Human Tissue Act 2004 covers England, Wales and Northern Ireland. It established the HTA to regulate activities concerning the removal, storage, use and disposal of human tissue. If the proposed project involves human tissue, the College of Medicine must be satisfied that the regulations are adhered to. All projects will be risk assessed by MRI physicist and approval must occur before the project commences. All projects will need to confirm insurance and professional liability cover. Advice on this can be sort from the Clinical Imaging Team.

All applications will be required to read and understand the CIF Standard Operating Procedure Terms and Conditions and comply with any relevant training program if necessary. The agreement is required to be signed by all parties and a copy retained in the project file. When  the study is approved by CIF, the Principle Investigator (PI) will receive a project confirmation email  with a CIF project number. Book scanning time can then proceed.

Project Initiation:Once the project number has been received the project can start, all day to day book of tie slots on the scanner should be made via CifGroup@swansea.ac.uk   All slots require confirmation. The participant’s  consent and screening for contra-indications should be undertaken before the appointment time.


A dedicated team of imaging research staff, from diverse backgrounds with experience in MRI and CT specialist fields. The Chair of Imaging  heads up the departments and is assisted by an Operational Lead,  a Clinical Scientist and Unit Administrator.  There are collaboration links to the Psychological Department in Human And Health Sciences, Engineering, Computer Sciences, Medical Physics and Sport sciences within the University. There are also strong links with ABMU, cardiology, radiology and orthopaedic departments.

Rhodri M Evans – Chair of Imaging, Consultant Radiologist  

Paola Griffiths -  Operational Lead, Superintendent Research Radiographer

Dr Jonathan Phillips – Clinical Scientist,  Medical Imaging Physicist 

Laura Lowe – Unit Administrator

Collaborators: include university and NHS staff, as well as external companies (see below). Please contact us CIFGroup@swansea.ac.ukif you are interested in collaboration or would like further information about CIF research.

Acuitus Medical Ltd.
Dr. Parvaiz Ali, NHS (nuclear medicine)
Dr. Frederic Boy, Psychology (cognitive neuroscience, brain imaging, GABA MR spectroscopy, transcranial DC stimulation)
Dr. Richard Bracken, Sport and Exercise Science (exercise, nutrition, diabetes)
Dr. Simon Dymond , Psychology (neurobehavioural mechanisms of fear and avoidance generalization, conditioned reinforcement and perceptual generalisation in gambling disorder)
Dr. Richard Hugtenburg, Imaging in radiotherapy; imaging and modelling of tissue structures on the micron and nanoscale; MR structural analysis in collaboration with Acuitas Medical Ltd.
Dr. Stephen Johnston, Psychology (cognitive neuroscience)
Dr. Frank Langbein, Cardiff Computer Science (modelling and control, machine learning, parallel algorithms, geometry and image processing, visualisation)
Dr. Raoul van Loon, Medical Engineering
Dr. Owen Pickrell,Medicine (genetics, neurological disorders, epilepsy)
Professor. Mark Rees, Epilepsy, hyperekplexia, cortical malformations, Huntington’s disease, dementia
Dr. Caryl Richards, Aberystwyth Physics (whole body DWI)
Dr. Sophie Schirmer, Physics (quantum control)
Prof. Gareth Stratton, Sport and Exercise Science (physical activity, exercise, fitness, MRS, NAFLD, body composition, diabetes, cancer)
Dr. Andrea Tales, Psychology (dementia, mild cognitive impairment, subjective cognitive impairment, ageing, vision, visual attention, visual mismatch negativity)
Dr. Roger Wood, Medicine (traumatic brain injury)